Imricor Medical Systems, Inc. (ASX:IMR)

Imricor Medical Systems Ratios and Metrics

Market cap in millions AUD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 15, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	603	367	96	55	144	284
Market Cap Growth	71.13%	281.62%	74.29%	-61.62%	-49.27%	155.25%
Enterprise Value	564	379	103	45	126	271
Last Close Price	1.88	1.36	0.55	0.35	0.97	2.19
PS Ratio	528.47	237.01	106.62	46.01	150.33	311.76
PB Ratio	17.14	-30.82	-7.50	5.00	4.67	7.60
P/TBV Ratio	17.14	-	-	5.00	4.67	7.60
EV/Sales Ratio	-	244.66	114.13	37.28	131.63	298.01
Debt / Equity Ratio	1.08	-2.88	-1.22	0.59	0.08	0.09
Asset Turnover	0.02	0.06	0.06	0.04	0.02	0.03
Inventory Turnover	1.13	1.18	0.88	0.96	0.92	0.51
Quick Ratio	25.34	6.81	0.27	2.80	6.81	11.03
Current Ratio	26.23	7.79	0.86	4.67	8.30	12.58
Return on Equity (ROE)	-432.29%	-	-	-116.05%	-77.05%	-69.44%
Return on Assets (ROA)	-38.22%	-68.06%	-95.73%	-53.19%	-41.90%	-33.90%
Return on Capital (ROIC)	-47.54%	-128.95%	-151.39%	-59.77%	-45.67%	-37.07%
Return on Capital Employed (ROCE)	-36.10%	-84.60%	-450.70%	-148.50%	-84.00%	-38.20%
Earnings Yield	-9.09%	-13.06%	-34.47%	-46.23%	-18.85%	-5.69%
FCF Yield	-4.29%	-6.88%	-19.90%	-44.61%	-17.31%	-5.93%
Buyback Yield / Dilution	-57.17%	-43.03%	-7.46%	-11.42%	-18.76%	-81.97%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.